Learn about a treatment for postmenopausal osteoporosis
with a FREE guide for On-the-Go Women

Meet the once-yearly osteoporosis treament

Important Safety Information

Here's a chance to sign up for your FREE Guide for On-The-Go Women so you can learn more about Reclast. With your guide, you'll find out how one annual intravenous (IV) dose helps strengthen your bones and protect them from fracture for an entire year. You'll also learn what to expect from treatment, and questions to ask your doctor, so you can make the most of your talk.

By signing up now, you'll also have the opportunity to be a part of R Lifestyle, a special program for on-the-go women who receive, or are considering treatment with prescription Reclast. As a member of R Lifestyle, you'll have access to lively features on beauty, health and fitness at RLifestyleOnline.com.

We'll also send you an appointment reminder for your next annual Reclast treatment.

The personal information you supply to us will be shared with and among our business partners, affiliates, and agents to provide you with information, products, programs and services, and to conduct market research. Your information will not be used by any of our business partners, affiliates and/or agents for their own separate marketing purposes. You have the right to cancel your participation at any time by calling 1-888-NOW-NOVA (1-888-669-6682). For further information about Novartis Pharmaceuticals Corporation privacy practices, please review our Privacy Policy.

By providing my information and clicking "Continue" I agree to receive requested materials, marketing information about Reclast, as well as other related health issues. I permit Novartis Pharmaceuticals Corporation to use my personal information as described in the notice listed above and as specified in the privacy policy.



* Required fields

Title*
First name*
Last name*
Street address*
 
City*
State*
ZIP code*
Phone * - -
Email*
Email confirm*
Have you been diagnosed with Osteoporosis?* Yes No
Are you requesting this material for* Yourself Someone else


In order to receive materials from Reclast you must be 18 years of age.
Please confirm by providing your date of birth.*

Date of Birth: / /

Have you received Reclast?*
Yes (please provide treatment date) No, I would like to learn more about Reclast.
/ / No, I am waiting to use up my current prescription.

If no, have you scheduled an appointment?*
Yes (please provide treatment date) No, I'm not sure where to go for treatment.
/ / No, I have more questions for my doctor.
No, I am satisfied with my current therapy.

‡ Please be aware that emails you opt to receive via text messaging (wireless email) can be subject to fees from your cellular provider.



Complete the following survey by clicking on the circle below your response. The survey asks no more than five questions and should only take a few minutes to complete. Your input is greatly appreciated.

How bothersome is your osteoporosis?

Not at all
bothersome
Extremely
bothersome
1 2 3 4 5 6 7

Prescription Reclast is approved for the treatment of postmenopausal osteoporosis.

Important Safety Information

You should not take Reclast if you're on Zometa® (zoledronic acid) Injection as it contains the same ingredient; if you have low blood calcium, kidney problems, or are allergic to Reclast or Zometa. Or you're pregnant, plan to become pregnant or nursing.

It's important to drink fluids before getting Reclast to help prevent kidney problems. The most common side effects are flu-like symptoms, fever, muscle or joint pain and headache. Tell your doctor if you have dental problems because rarely, problems with the jaw have been reported with Reclast. Discuss all medicines you're taking, including prescription and non-prescription, vitamins and herbal supplements. If you develop severe bone, joint or muscle pain, numbness, tingling or muscle spasms, contact your doctor.

Please see Product Information.

Novartis Pharmaceuticals Corporation Pharma US Use of website is governed by the Terms of Use and Privacy Statement.
Copyright ©2008
Novartis Pharmaceuticals Corporation. All rights reserved.